Mengis Capital Management, Inc. Pfizer Inc Transaction History

Mengis Capital Management, Inc.

$456 Million
Q2 2025

A detailed history of Mengis Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 58,656 shares of PFE stock, worth $1.4 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

58,656

Previous 58,657 0.0%

Holding current value

$1.4 Million

Previous $1.49 Million 4.37%

% of portfolio

0.31%

Previous 0.32%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$21.59 - $24.84 $21 - $24	-1 Reduced -0.0%	58,656 $1.42 Million
Q1 2025 May 08, 2025	SELL	$25.01 - $27.13 $156,412 - $169,671	-6,254 Reduced 9.63%	58,657 $1.49 Million
Q4 2024 Feb 04, 2025	SELL	$24.8 - $30.19 $14,880 - $18,114	-600 Reduced 0.92%	64,911 $1.72 Million
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $110,855 - $125,622	-4,002 Reduced 5.76%	65,511 $1.9 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $201,726 - $236,385	-7,986 Reduced 10.3%	69,513 $1.94 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $358,550 - $411,730	13,849 Added 21.76%	77,499 $2.15 Million
Q4 2023 Feb 01, 2024	BUY	$26.13 - $33.94 $14,371 - $18,667	550 Added 0.87%	63,650 $1.83 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $22,495 - $26,294	-701 Reduced 1.1%	63,100 $2.09 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $28,895 - $33,432	-800 Reduced 1.24%	63,801 $2.34 Million
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $354 - $461	9 Added 0.01%	64,601 $2.64 Million
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $6,053 - $7,902	-145 Reduced 0.22%	64,592 $3.31 Million
Q3 2022 Nov 04, 2022	SELL	$43.76 - $53.42 $174,821 - $213,412	-3,995 Reduced 5.81%	64,737 $2.83 Million
Q2 2022 Jul 19, 2022	SELL	$46.53 - $55.17 $18,425 - $21,847	-396 Reduced 0.57%	68,732 $3.6 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $12,123 - $15,022	-265 Reduced 0.38%	69,128 $3.58 Million
Q4 2021 Feb 04, 2022	SELL	$41.32 - $61.25 $200,278 - $296,878	-4,847 Reduced 6.53%	69,393 $4.1 Million
Q3 2021 Nov 03, 2021	BUY	$39.25 - $50.42 $588 - $756	15 Added 0.02%	74,240 $3.19 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $108,771 - $123,219	-3,029 Reduced 3.92%	74,225 $2.91 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $24,179 - $27,269	-722 Reduced 0.93%	77,254 $2.8 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $124,976 - $158,919	3,734 Added 5.03%	77,976 $2.87 Million
Q3 2020 Oct 29, 2020	SELL	$31.75 - $37.25 $30,321 - $35,573	-955 Reduced 1.27%	74,242 $2.72 Million
Q2 2020 Jul 22, 2020	SELL	$30.12 - $36.54 $15,662 - $19,000	-520 Reduced 0.69%	75,197 $2.46 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $12,001 - $17,147	-444 Reduced 0.58%	75,717 $2.47 Million
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $31,109 - $35,305	-945 Reduced 1.23%	76,161 $2.98 Million
Q3 2019 Nov 05, 2019	BUY	$32.49 - $42.13 $29,078 - $37,706	895 Added 1.17%	77,106 $2.77 Million
Q2 2019 Jul 18, 2019	BUY	$36.98 - $41.52 $1.66 Million - $1.87 Million	44,961 Added 143.88%	76,211 $3.3 Million
Q1 2019 May 06, 2019	SELL	$37.5 - $41.2 $164,850 - $181,115	-4,396 Reduced 12.33%	31,250 $1.33 Million
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $188,349 - $214,738	-4,896 Reduced 12.08%	35,646 $1.56 Million
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $21,991 - $26,674	-638 Reduced 1.55%	40,542 $1.79 Million
Q2 2018 Jul 24, 2018	SELL	$32.98 - $35.16 $84,923 - $90,536	-2,575 Reduced 5.89%	41,180 $1.49 Million
Q1 2018 Apr 27, 2018	BUY	$31.91 - $37.02 $127 - $148	4 Added 0.01%	43,755 $1.55 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $11,108 - $11,786	334 Added 0.77%	43,751 $1.58 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $1.35 Million - $1.48 Million	43,417	43,417 $1.55 Million

Others Institutions Holding PFE

# of Institutions

3,341

Shares Held

3.6B

Call Options Held

104M

Put Options Held

129M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $134B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.

Account

Mengis Capital Management, Inc. Pfizer Inc Transaction History